Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Talmapimod

Catalog No. T12871Cas No. 309913-83-5
Alias SCIO-469

Talmapimod (SCIO-469) is a selective, orally active, ATP-competitive p38α inhibitor with IC50 values of 9 nM for p38α and 90 nM for p38β. Talmapimod exhibits at least 2000-fold selectivity over a panel of 20 kinases, including other MAPKs.

Talmapimod

Talmapimod

Purity: 100%
Catalog No. T12871Alias SCIO-469Cas No. 309913-83-5
Talmapimod (SCIO-469) is a selective, orally active, ATP-competitive p38α inhibitor with IC50 values of 9 nM for p38α and 90 nM for p38β. Talmapimod exhibits at least 2000-fold selectivity over a panel of 20 kinases, including other MAPKs.
Pack SizePriceAvailabilityQuantity
1 mg$48In Stock
2 mg$70In Stock
5 mg$117In Stock
10 mg$187In Stock
25 mg$397In Stock
50 mg$589In Stock
100 mg$843In Stock
1 mL x 10 mM (in DMSO)$133In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Talmapimod"

Select Batch
Purity:100%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Talmapimod (SCIO-469) is a selective, orally active, ATP-competitive p38α inhibitor with IC50 values of 9 nM for p38α and 90 nM for p38β. Talmapimod exhibits at least 2000-fold selectivity over a panel of 20 kinases, including other MAPKs.
Targets&IC50
p38α:9 nM, p38β:90 nM
In vitro
phosphorylation of p38 MAPK inhibited by Talmapimod (100-200 nM; 1 hour) in MM cells[1].In human whole blood, LPS-induced TNF-a production inhibited by Talmapimod [2]. Talmapimod decreases constitutive p38alpha MAPK phosphorylation of both 5T2MM and 5T33MM cells[3].
In vivo
Talmapimod (SCIO-469), targeting p38α MAPK, reduces myeloma burden and prevents myeloma bone disease[2]. In 5T2MM and 5T33MM models, it inhibits multiple myeloma growth and bone diseases[3]. Administered at 10-90 mg/kg orally, twice daily for 14 days, Talmapimod dose-dependently diminishes tumor growth and decreases the weight of palpable tumors at termination[4].
AliasSCIO-469
Chemical Properties
Molecular Weight513
FormulaC27H30ClFN4O3
Cas No.309913-83-5
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 95 mg/mL (185.19 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9493 mL9.7466 mL19.4932 mL97.4659 mL
5 mM0.3899 mL1.9493 mL3.8986 mL19.4932 mL
10 mM0.1949 mL0.9747 mL1.9493 mL9.7466 mL
20 mM0.0975 mL0.4873 mL0.9747 mL4.8733 mL
50 mM0.0390 mL0.1949 mL0.3899 mL1.9493 mL
100 mM0.0195 mL0.0975 mL0.1949 mL0.9747 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Talmapimod | purchase Talmapimod | Talmapimod cost | order Talmapimod | Talmapimod chemical structure | Talmapimod in vivo | Talmapimod in vitro | Talmapimod formula | Talmapimod molecular weight